当前位置： SCI文献检索 > EXPERIMENTAL HEMATOLOGY期刊下所有文献 > Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1.

Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1.

Abstract：

OBJECTIVE:Myeloid ectropic viral integration site 1 (MEIS1) is a Hox cofactor known for its role in development and is strongly linked to normal and leukemic hematopoiesis. Although previous studies have focused on identifying protein partners of MEIS1 and its transcriptionally regulated targets, little is known about the upstream transcriptional regulators of this tightly regulated gene. Understanding the regulation of MEIS1 is important to understanding normal hematopoiesis and leukemogenesis. MATERIALS AND METHODS:Here we describe our studies focusing on the evolutionary conserved putative MEIS1 promoter region. Phylogenetic sequence analysis and reporter assays in MEIS1-expressing (K562) and nonexpressing (HL60) leukemic cell line models were used to identify key regulatory regions and potential transcription factor binding sites within the candidate promoter region followed by functional and expression studies of one identified regulator in both cell lines and primary human cord blood and leukemia samples. RESULTS:Chromatin status of MEIS1 promoter region is associated with MEIS1 expression. Truncation and mutation studies coupled with reporter assays revealed that a conserved ETS family member binding site located 289 bp upstream of the annotated human MEIS1 transcription start site is required for promoter activity. Of the three ETS family members tested, only ELF1 was enriched on the MEIS1 promoter as assessed by both electrophoretic mobility shift assay and chromatin immunoprecipitation experiments in K562. This finding was confirmed in MEIS1-expressing primary human samples. Moreover, small interfering RNA-mediated knockdown of ELF1 in K562 cells was associated with a decreased MEIS1 expression. CONCLUSIONS:We conclude that the ETS transcription factor ELF1 is an important positive regulator of MEIS1 expression.

journal_name

Exp Hematol

journal_title

Experimental hematology

authors

Xiang P,Lo C,Argiropoulos B,Lai CB,Rouhi A,Imren S,Jiang X,Mager D,Humphries RK

doi

10.1016/j.exphem.2010.06.006

subject

Has Abstract

pub_date

2010-09-01 00:00:00

pages

798-8, 808.e1-2

issue

9

eissn

0301-472X

issn

1873-2399

pii

S0301-472X(10)00241-9

journal_volume

38

pub_type

杂志文章

相关文献

EXPERIMENTAL HEMATOLOGY文献大全
  • Fluctuations of BFUe and CFUe cycling after erytrhoid perturbations: correlation with variations of pool size.

    abstract：:The pool size of erythroid burst-(BFUe) and colony-forming units (CFUe) has been evaluated in normal or hypoxia-induced polycythemic mice at sequential times after either transfusion or administration of purified erythropoietin (Ep). The present investigations were focused on the in vitro tritiated thymidine (3H-TdR) ...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Peschle C,Cillo C,Migliaccio G,Lettieri F

    更新日期：1980-01-01 00:00:00

  • Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells.

    abstract：:We previously demonstrated that lysis of tumor cells that express Hsp70, the highly stress-inducible member of the HSP70 family, on their plasma membrane is mediated by natural killer (NK) cells. Here, we studied the effects of different proteins of the HSP70 family in combination with interleukin 2 (IL-2) on the prol...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/s0301-472x(99)00104-6

    authors： Multhoff G,Mizzen L,Winchester CC,Milner CM,Wenk S,Eissner G,Kampinga HH,Laumbacher B,Johnson J

    更新日期：1999-11-01 00:00:00

  • Prdm3 and Prdm16 cooperatively maintain hematopoiesis and clonogenic potential.

    abstract：:Mds1-Evi1 (also known as Prdm3) and Prdm16 are two highly related zinc finger transcription factors that, within the hematopoietic system, are both expressed primarily in hematopoietic stem cells (HSCs). Our laboratory previously found that constitutive Mds1-Evi1 knockout mice are viable, but their HSCs are unable to ...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/j.exphem.2020.04.010

    authors： McGlynn KA,Sun R,Vonica A,Rudzinskas S,Zhang Y,Perkins AS

    更新日期：2020-05-01 00:00:00

  • Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors.

    abstract：OBJECTIVE:Potent immunosuppressants, such as rapamycin, FK506, and ascomycin, are known to regulate the phosphorylation of proteins. The purpose of this study was to investigate the effects of these immunosuppressants on differentiation of several human myeloid leukemic cell lines. MATERIALS AND METHODS:Human myeloid ...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/s0301-472x(01)00626-9

    authors： Yamamoto-Yamaguchi Y,Okabe-Kado J,Kasukabe T,Honma Y

    更新日期：2001-05-01 00:00:00

  • JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.

    abstract：OBJECTIVE:Among Philadelphia chromosome-negative myeloproliferative neoplasms (Ph(-) MPN), essential thrombocythemia (ET) and the prefibrotic phase of primary myelofibrosis (PMF) represent two subtypes with considerable overlap. MATERIALS AND METHODS:In this study, histopathological classification of 490 MPN cases was...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/j.exphem.2009.07.005

    authors： Hussein K,Bock O,Theophile K,von Neuhoff N,Buhr T,Schlué J,Büsche G,Kreipe H

    更新日期：2009-10-01 00:00:00

  • Final checkup of neoplastic DNA replication: evidence for failure in decision-making at the mitotic cell cycle checkpoint G(1)/S.

    abstract：OBJECTIVES:Processing of epigenomic transcriptional information by cell cycle phase G(1) and decision-making at checkpoint G(1)/S are the final organizational steps preceding gene replication in transcriptional reorientation programs (i.e., switches from proliferation to cycle arrest and neoplastic transformation). Fur...

    journal_title：Experimental hematology

    pub_type： 杂志文章,评审

    doi：10.1016/j.exphem.2008.07.009

    authors： Prindull G

    更新日期：2008-11-01 00:00:00

  • A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.

    abstract：OBJECTIVE:We monitored cytokine-secreting cells using an enzyme-linked immunospot (ELISPOT) assay in a prospective study to assess the cytokine network after transplantation. PATIENTS AND METHODS:Peripheral blood mononuclear cells were collected from 23 patients who received allogeneic stem cell transplantation, from ...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/j.exphem.2004.10.009

    authors： Takabayashi M,Kanamori H,Takasaki H,Yamaji S,Koharazawa H,Taguchi J,Tomita N,Fujimaki K,Fujisawa S,Maruta A,Ishigatsubo Y

    更新日期：2005-02-01 00:00:00

  • Granulocyte transfusions in recovery of neutropenic rats from induced E. coli toxicemia.

    abstract：:Rats made transiently neutropenic by intra-arterial administration of vinblastine (3 mg/kg) and infected with E. coli (6.02+/-0.45 X 10(8), per animal) have a mortality rate of 90% within 48 h post infection. Multiple transfusions of large numbers of granulocytes (harvested from Deca-Durabolin treated donor rats) prot...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Popovic V,Schaffer R,Popovic P

    更新日期：1977-05-01 00:00:00

  • Growth-inhibitory effect of 2-CdA on myeloid CFU-GM progenitors in normal human long-term bone marrow cultures and its compensation by G-CSF or IL-3.

    abstract：:As neutropenia is a common side effect of treatment with 2-chlorodeoxyadenosine (2-CdA), we investigated the myelosuppressive action of 2-CdA in Dexter-type human long-term bone marrow cultures (LTBMCs). LTBMCs were incubated with varying doses of 2-CdA (5 to 20 nM/L) during the first week. At 20 and 10 nM/L 2-CdA, we...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Petzer AL,Geisen FH,Bilgeri R,Zilian U,Haun M,Herold M,Braunsteiner H,Konwalinka G

    更新日期：1995-06-01 00:00:00

  • Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma.

    abstract：OBJECTIVE:To investigate the mechanisms of antiproliferative effect induced by the mammalian target of rapamycin (mTOR) inhibitor temsirolimus in mantle cell lymphoma (MCL). MATERIALS AND METHODS:The antiproliferative effect of temsirolimus on three well-defined MCL cell lines was examined by the MTS assay. Induction ...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/j.exphem.2007.12.008

    authors： Yazbeck VY,Buglio D,Georgakis GV,Li Y,Iwado E,Romaguera JE,Kondo S,Younes A

    更新日期：2008-04-01 00:00:00

  • Frequency and differentiation capacity of circulating LTC-IC mobilized by G-CSF or GM-CSF following chemotherapy: a comparison with steady-state bone marrow and peripheral blood.

    abstract：OBJECTIVE:The present study was designed to compare directly the frequency of circulating LTC-IC and E-LTC-IC mobilized in peripheral blood (PB) after chemotherapy supported by either G-CSF (PB-G) or GM-CSF (PB-GM) in comparison to steady-state bone marrow (BM) and PB (PB-ST) values in the same patients. MATERIALS AND...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/s0301-472x(01)00762-7

    authors： Benboubker L,Binet C,Cartron G,Bernard MC,Clement N,Delain M,Degenne M,Desbois I,Colombat P,Domenech J

    更新日期：2002-01-01 00:00:00

  • Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.

    abstract：:High-dose chemotherapy followed by autologous bone marrow transplantation (ABMT) in the treatment of malignancies is often associated with immune deficiency following transplantation, possibly contributing to tumor relapse or fatal infection. Interleukin 2 (IL-2), which enhances major histocompatibility complex (MHC)-...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Bosly A,Guillaume T,Brice P,Humblet Y,Staquet P,Doyen C,Chatelain B,Franks CR,Gisselbrecht C,Symann M

    更新日期：1992-09-01 00:00:00

  • Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.

    abstract：:Several prospective randomized trials in acute myelocytic leukemia (AML) documented a lower relapse rate with autologous bone marrow transplantation (ABMT) than with conventional chemotherapy. However, they also identified some transplant difficulties, such as failure to collect sufficient numbers of stem cells, slow ...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/s0301-472x(99)00121-6

    authors： Gorin NC,Labopin M,Laporte JP,Douay L,Lopez M,Lesage S,Fouillard L,Isnard F,Jouet JP,Bellal N,Perot C,Van Den Akker J,Bauters F,Najman A

    更新日期：1999-12-01 00:00:00

  • Modeling of hematologic malignancies by iPS technology.

    abstract：:Induced pluripotent stem cells (iPSCs) can be generated from various types of cells with transduction of defined transcription factors. Patient-derived iPSCs are becoming commonly utilized for understanding the molecular pathways involved in disease and for the development of novel targeted therapies. With the use of ...

    journal_title：Experimental hematology

    pub_type： 杂志文章,评审

    doi：10.1016/j.exphem.2015.06.006

    authors： Arai S,Miyauchi M,Kurokawa M

    更新日期：2015-08-01 00:00:00

  • Effect of in vitro treatment with indomethacin on mouse granulocyte-macrophage colony-forming cells in culture (CFUC). Possible role of prostaglandins.

    abstract：:The effect of indomethacin (6 mg/kg daily orally for 2, 3 or 4 days) on myelopoiesis was studied in mice by estimating 1) differential cell counts of bone marrow, 2) proliferation of the CFUC in presence of GM-CSF, 3) proliferative state of CFUC after tritiated thymidine suicide. After 4 days of treatment, a rise in t...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Fontagné J,Adolphe M,Semichon M,Zizine L,Lechat P

    更新日期：1980-10-01 00:00:00

  • Effects of androgen on transient endogenous spleen colonies and other hemopoietic stem cells in mice.

    abstract：:To clarify the effects of androgen on hemopoiesis in mice, we investigated changes in hemopoietic stem cells at various stages of differentiation after injection of 19-nandrolone decanoate (19-ND). 19-ND induced (a) a marked increase in the population of CFUe, especially in the spleen, and (b) a less significant incre...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Kamamoto T,Sakoda H,Yoshida Y,Uchino H,Imai N,Mori KJ

    更新日期：1985-08-01 00:00:00

  • Deconstructing innate immune signaling in myelodysplastic syndromes.

    abstract：:Overexpression of immune-related genes is widely reported in myelodysplastic syndromes (MDSs), and chronic immune stimulation increases the risk for developing MDS. Aberrant innate immune activation, such as that caused by increased toll-like receptor (TLR) signaling, in MDS can contribute to systemic effects on hemat...

    journal_title：Experimental hematology

    pub_type： 杂志文章,评审

    doi：10.1016/j.exphem.2015.05.016

    authors： Varney ME,Melgar K,Niederkorn M,Smith M,Barreyro L,Starczynowski DT

    更新日期：2015-08-01 00:00:00

  • Immature platelet fraction as a useful marker in the etiological determination of thrombocytopenia.

    abstract：:The etiology of thrombocytopenia is important in treatment and management of the condition. Most platelet parameters that are routinely analyzed in the diagnostic laboratory have not proven useful in identifying the etiology, while specialized assays suffer from poor standardization and lack of agreement between labor...

    journal_title：Experimental hematology

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1016/j.exphem.2019.09.001

    authors： Ali I,Graham C,Dempsey-Hibbert NC

    更新日期：2019-10-01 00:00:00

  • Mutagenic and toxic effects of 4-hydroperoxycyclophosphamide and of 2,4-tetrahydrocyclohexylamine (ASTA-Z-7557) on human lymphocytes cultured in vitro.

    abstract：:Certain biological effects exerted by 4-hydroperoxycyclophosphamide and by 2,4-tetrahydrocyclohexylamine (ASTA-Z-7557), utilized in vitro in the therapy of leukemias and lymphomas to eliminate the occult tumor cells in autologous marrow transplantations, were studied in human lymphocytes cultured in vitro. The data sh...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Perocco P,Pane G,Santucci MA,Zannotti M

    更新日期：1985-11-01 00:00:00

  • Thyroid hormones enhance hypoxia-induced erythropoietin production in vitro.

    abstract：:Effects of thyroid hormones on the production of erythropoietin (Epo) were investigated in isolated perfused rat kidneys and in the human hepatoma cell line, HepG2. Epo protein was measured by radioimmunoassay. L-triiodothyronine and L-thyroxine stimulated hypoxia-induced Epo formation both in the kidney and in HepG2 ...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Fandrey J,Pagel H,Frede S,Wolff M,Jelkmann W

    更新日期：1994-03-01 00:00:00

  • c-jun and c-fos are expressed by human megakaryocytes.

    abstract：:Expression of the main nuclear protooncogenes during terminal megakaryocyte (MK) differentiation is poorly understood. Because previous results have suggested that c-fos and c-jun protooncogenes are expressed in human leukemic cell lines induced to undergo megakaryocytic differentiation, we have analyzed the expressio...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Mouthon MA,Navarro S,Katz A,Breton-Gorius J,Vainchenker W

    更新日期：1992-08-01 00:00:00

  • Binding of macrophage colony-stimulating factor to serum proteins.

    abstract：:Although three molecular forms of macrophage colony-stimulating factor (M-CSF) have been reported, Western blot analysis of immunoaffinity-purified M-CSF from human blood has shown that the major species of M-CSF in the serum has a molecular weight (MW) of 85 kD. Superose-12 gel filtration chromatography of immunoaffi...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Ohtsuki T,Hatake K,Ikeda M,Yamada M,Motoyoshi K,Miura Y

    更新日期：1996-02-01 00:00:00

  • Beyond "to divide or not to divide": Kinetics matters in hematopoietic stem cells.

    abstract：:Lifelong blood production is ensured by a population of rare and largely quiescent, long-lived hematopoietic stem cells (HSCs). The advent of single-cell technologies has recently highlighted underlying molecular and functional heterogeneity within the HSC pool. Despite heterogenous HSC behaviors, quiescence remains a...

    journal_title：Experimental hematology

    pub_type： 杂志文章,评审

    doi：10.1016/j.exphem.2020.11.003

    authors： Johnson C,Belluschi S,Laurenti E

    更新日期：2020-12-01 00:00:00

  • Combined corticosteroid/granulocyte colony-stimulating factor (G-CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G-CSF: Activated glucocorticoid receptors synergize with G-CSF signals.

    abstract：:More than 90% of patients with severe congenital neutropenia (SCN) respond to granulocyte colony-stimulating factor (G-CSF) therapy. The basis for the refractory state in the remaining patients is unknown. To address this issue, we studied a child with SCN who was totally unresponsive to G-CSF and had a novel point mu...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/s0301-472x(00)00544-0

    authors： Dror Y,Ward AC,Touw IP,Freedman MH

    更新日期：2000-12-01 00:00:00

  • Efficiency of human HLA-mismatched CD34+ cells from unrelated donors in establishing in vitro hematopoiesis in allogeneic long-term marrow cultures.

    abstract：:We have examined the capacity of highly purified human CD34+ marrow cell isolates from unrelated, HLA-mismatched donors to establish in vitro hematopoiesis on recipient marrow stromal cells in 2-stage hematopoietic long-term marrow cultures (H-LTMC). HLA-typing of both peripheral blood mononuclear cells and CD34+ marr...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： La Russa VF,Kessler SW,Henson VA,Cutting M,Polsinelli T,Knight RD,Wright DG

    更新日期：1996-11-01 00:00:00

  • Kinetics of lentiviral vector transduction in human CD34(+) cells.

    abstract：:Unlike cell lines, human hematopoietic stem cells (HSCs) are less efficiently transduced with HIV-1 vectors, potentially limiting this approach. To investigate which step (internalization, reverse transcription, nuclear transport, and integration) limits lentiviral transduction, we evaluated the kinetics of lentiviral...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/j.exphem.2015.10.003

    authors： Uchida N,Green R,Ballantine J,Skala LP,Hsieh MM,Tisdale JF

    更新日期：2016-02-01 00:00:00

  • Heterozygous kit mutants with little or no apparent anemia exhibit large defects in overall hematopoietic stem cell function.

    abstract：OBJECTIVE:The evolutionarily conserved Kit receptor is vital for function of hematopoietic stem cells (HSC). Kit(W-41) (W-41) and Kit(W-42) (W-42) are single residue changes in the KIT intracellular phosphotransferase domain, while Kit(W-v) (W-v) is a single residue change in the ATP binding domain. This study tests ho...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/j.exphem.2006.10.001

    authors： Sharma Y,Astle CM,Harrison DE

    更新日期：2007-02-01 00:00:00

  • In vivo regulation of hemopoiesis by transforming growth factor beta 1: stimulation of GM-CSF- and M-CSF-dependent murine bone marrow precursors.

    abstract：:Injection of mice with either natural bovine bone-derived or human recombinant transforming growth factor beta 1 (TGF-beta 1) resulted in a significant increase of the macrophage and macrophage-granulocyte-forming capacity of their macrophage colony-stimulating factor (M-CSF)- and granulocyte-macrophage colony-stimula...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Bursuker I,Neddermann KM,Petty BA,Schacter B,Spitalny GL,Tepper MA,Pasternak RD

    更新日期：1992-05-01 00:00:00

  • Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.

    abstract：OBJECTIVE:The aim of this study was to develop an animal model for human acute lymphoblastic leukemia (ALL) in which the kinetics and characteristics of leukemia can be sequentially monitored in individual mice. MATERIALS AND METHODS:NOD/SCID mice were inoculated intravenously with primary ALL. Progression of leukemia...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：10.1016/s0301-472x(00)00669-x

    authors： Nijmeijer BA,Mollevanger P,van Zelderen-Bhola SL,Kluin-Nelemans HC,Willemze R,Falkenburg JH

    更新日期：2001-03-01 00:00:00

  • Expression of interleukin 6 and its specific receptor by untreated and PMA-stimulated human erythroid and megakaryocytic cell lines.

    abstract：:Different human hematopoietic cell lines were analyzed for the presence of interleukin 6 (IL-6) and IL-6 receptor (IL-6-R). Both IL-6 mRNA and secreted active IL-6 protein were detectable in untreated cell lines with erythroid or megakaryoblastic features (K562, HEL, KU 812, MEG-01, and Dami), but they were not expres...

    journal_title：Experimental hematology

    pub_type： 杂志文章

    doi：

    authors： Navarro S,Mitjavila MT,Katz A,Doly J,Vainchenker W

    更新日期：1991-01-01 00:00:00